CD46 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD46 monoclonal antibodies for research applications. CD46 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD46, also known as membrane cofactor protein, plays a crucial role in the regulation of the complement system, which is essential for immune response and inflammation. CD46 is involved in protecting host cells from complement-mediated lysis and has been implicated in various physiological and pathological processes, including viral infections and autoimmune diseases. The study of CD46 continues to reveal new insights into immune system function and disease progression. Understanding CD46's molecular mechanisms can lead to improved therapeutic approaches for complement-related disorders. Research focusing on CD46 has significant implications for developing new treatment strategies in immunology and infectious diseases. Santa Cruz Biotechnology monoclonal antibodies for CD46 support researchers worldwide in advancing scientific understanding of immune regulation and disease mechanisms.